Evidence map›Paper›PMID 29116176›Full record

ArticleScientific reports2017

Redefining viability by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction.

Heerajnarain Bulluck, Stefania Rosmini, Amna Abdel-Gadir, Anish N Bhuva, Thomas A Treibel, Marianna Fontana, Daniel S Knight, Sabrina Nordin, Alex Sirker, Anna S Herrey and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05374265 (Cardiovascular Magnetic Resonance Guided Open Artery Trial for Revascularization of Late Presenting ST Elevation Myocardial Infarction), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05374265 nawithdrawnnot on this mapstarted 2022, after this paper: background citation

Cardiovascular Magnetic Resonance Guided Open Artery Trial for Revascularization of Late Presenting ST Elevation Myocardial Infarction: The CRM-OAT Pilot Trial

TypeinterventionalSponsorSheffield Teaching Hospitals NHS Foundation TrustRan2022 to 2023Enrolled0ConditionsSTEMIArmsCardiovascular Magnetic Resonance Scan
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Assessment of myocardial viability by cardiac MRI.Current opinion in cardiology · 2019
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Heerajnarain BulluckThe Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, London, UK. h.bulluck@gmail.com.ORCID 0000-0002-1985-1783
Stefania RosminiBarts Heart Centre, St Bartholomew's Hospital, London, UK.
Amna Abdel-GadirBarts Heart Centre, St Bartholomew's Hospital, London, UK.
Anish N BhuvaBarts Heart Centre, St Bartholomew's Hospital, London, UK.
Thomas A TreibelBarts Heart Centre, St Bartholomew's Hospital, London, UK.
Marianna FontanaThe National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK.
Daniel S KnightNational Amyloid Centre, Royal Free Hospital, London, UK.
Sabrina NordinBarts Heart Centre, St Bartholomew's Hospital, London, UK.
Alex SirkerThe National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK.
Anna S HerreyBarts Heart Centre, St Bartholomew's Hospital, London, UK.
Charlotte ManistyThe National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK.
James C MoonThe National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK.
Derek J HausenloyThe Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, London, UK.
St Bartholomew's Hospital · GBThe Royal Free Hospital · GBCardiovascular Institute of the South · US

Funding

British Heart Foundation CS/14/3/31002British Heart Foundation FS/10/039/28270British Heart Foundation FS/10/72/28568
6 · The paper itself

Abstract

In chronic myocardial infarction (MI), segments with a transmural extent of infarct (TEI) of ≤50% are defined as being viable. However, in the acute phase of an ST-segment elevation myocardial infarction (STEMI), late gadolinium enhancement (LGE) has been demonstrated to overestimate MI size and TEI. We aimed to identify the optimal cut-off of TEI by cardiovascular magnetic resonance (CMR) for defining viability during the acute phase of an MI, using ≤50% TEI at follow-up as the reference standard. 40 STEMI patients reperfused by primary percutaneous coronary intervention (PPCI) underwent a CMR at 4 ± 2 days and 5 ± 2 months. The large majority of segments with 1-25%TEI and 26-50%TEI that were viable acutely were also viable at follow-up (59/59, 100% and 75/82, 96% viable respectively). 56/84(67%) segments with 51-75%TEI but only 4/63(6%) segments with 76-100%TEI were reclassified as viable at follow-up. TEI on the acute CMR scan had an area-under-the-curve of 0.87 (95% confidence interval of 0.82 to 0.91) and ≤75%TEI had a sensitivity of 98% but a specificity of 66% to predict viability at follow-up. Therefore, the optimal cut-off by CMR during the acute phase of an MI to predict viability was ≤75% TEI and this would have important implications for patients undergoing viability testing prior to revascularization during the acute phase.

Indexed as

Coronary Artery BypassFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPercutaneous Coronary InterventionSensitivity and SpecificityST Elevation Myocardial Infarction

Identifiers

PMID29116176
PMCPMC5676975
OpenAlexW2766428901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.